Trevi Therapeutics

+$0.06 (+4.65%) As of 2:48 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.

About TRVI

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease.

CEO
Jennifer L. Good
Employees
22
Headquarters
New Haven, Connecticut
Founded
2011

TRVI Key Statistics

Market Cap
29.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.99K
High Today
$1.35
Low Today
$1.31
Open Price
$1.32
Volume
10.73K
52 Week High
$4.10
52 Week Low
$1.28

TRVI Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure